Рынок стартапов
← Все стартапы
Talus Bio

Talus Bio

YCS21

Discovering drugs that target the DNA regulome

/ 100
О компании

We have built a platform that enables drug discovery and development for previously undruggable genome regulators ("the regulome"). We accomplish this by moving drug discovery out of artificial systems where regulome proteins fail to function properly, and back into live human cells. Our technology combines innovations in automated cell processing, next-gen proteomics, and advanced data analytics to measure a drug's effect on the entire regulome in one experiment.

Команда
16 чел.
Статус
Active